Personal information

No personal information available

Activities

Collapse all

Works (46)

Publisher Correction: Immune evasion through mitochondrial transfer in the tumour microenvironment

Nature
2025-03-06 | Journal article
DOI: 10.1038/s41586-025-08764-y
Contributors: Hideki Ikeda; Katsushige Kawase; Tatsuya Nishi; Tomofumi Watanabe; Keizo Takenaga; Takashi Inozume; Takamasa Ishino; Sho Aki; Jason Lin; Shusuke Kawashima et al.
Source: check_circle
Crossref

Immune evasion through mitochondrial transfer in the tumour microenvironment

Nature
2025-02-06 | Journal article
DOI: 10.1038/s41586-024-08439-0
Contributors: Hideki Ikeda; Katsushige Kawase; Tatsuya Nishi; Tomofumi Watanabe; Keizo Takenaga; Takashi Inozume; Takamasa Ishino; Sho Aki; Jason Lin; Shusuke Kawashima et al.
Source: check_circle
Crossref

Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunity

Proceedings of the National Academy of Sciences
2024-08-27 | Journal article
DOI: 10.1073/pnas.2320189121
Contributors: Fumiaki Mukohara; Kazuma Iwata; Takamasa Ishino; Takashi Inozume; Joji Nagasaki; Youki Ueda; Ken Suzawa; Toshihide Ueno; Hideki Ikeda; Katsushige Kawase et al.
Source: check_circle
Crossref

CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

Cancer Research
2024-07-02 | Journal article
DOI: 10.1158/0008-5472.CAN-23-0453
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

Data from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.c.7311383.v1
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

Data from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.c.7311383
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

Figure S1 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144630
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

Figure S1 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144630.v1
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

Figure S2 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144627
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

Figure S2 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144627.v1
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

Figure S3 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144624.v1
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

Figure S3 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144624
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

Figure S4 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144621.v1
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

Figure S4 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144621
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

Figure S5 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144618
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

Figure S5 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144618.v1
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

Figure S6 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144615
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

Figure S6 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144615.v1
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

Figure S7 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144612
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

Figure S7 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144612.v1
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

Supplementary Table S6 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144609
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

Supplementary Table S6 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144609.v1
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

TableS1 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144606
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

TableS1 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144606.v1
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

TableS2 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144603
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

TableS2 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144603.v1
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

TableS3 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144600
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

TableS3 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144600.v1
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

TableS4 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144597
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

TableS4 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144597.v1
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

TableS5 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144594
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

TableS5 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling

2024-07-02 | Preprint
DOI: 10.1158/0008-5472.26144594.v1
Contributors: Yuto Naoi; Takao Morinaga; Joji Nagasaki; Ryo Ariyasu; Youki Ueda; Kazuo Yamashita; Wenhao Zhou; Shusuke Kawashima; Katsushige Kawase; Akiko Honobe-Tabuchi et al.
Source: check_circle
Crossref

Data from High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects

2023-07-05 | Preprint
DOI: 10.1158/2326-6066.c.6601461.v2
Contributors: Katsushige Kawase; Shusuke Kawashima; Joji Nagasaki; Takashi Inozume; Etsuko Tanji; Masahito Kawazu; Toyoyuki Hanazawa; Yosuke Togashi
Source: check_circle
Crossref

Data from High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects

2023-07-05 | Preprint
DOI: 10.1158/2326-6066.c.6601461
Contributors: Katsushige Kawase; Shusuke Kawashima; Joji Nagasaki; Takashi Inozume; Etsuko Tanji; Masahito Kawazu; Toyoyuki Hanazawa; Yosuke Togashi
Source: check_circle
Crossref

High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects

Cancer Immunology Research
2023-07-05 | Journal article
DOI: 10.1158/2326-6066.CIR-22-0815
Contributors: Katsushige Kawase; Shusuke Kawashima; Joji Nagasaki; Takashi Inozume; Etsuko Tanji; Masahito Kawazu; Toyoyuki Hanazawa; Yosuke Togashi
Source: check_circle
Crossref

Supplementary Figures from High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects

2023-07-05 | Preprint
DOI: 10.1158/2326-6066.23627519
Contributors: Katsushige Kawase; Shusuke Kawashima; Joji Nagasaki; Takashi Inozume; Etsuko Tanji; Masahito Kawazu; Toyoyuki Hanazawa; Yosuke Togashi
Source: check_circle
Crossref

Supplementary Figures from High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects

2023-07-05 | Preprint
DOI: 10.1158/2326-6066.23627519.v1
Contributors: Katsushige Kawase; Shusuke Kawashima; Joji Nagasaki; Takashi Inozume; Etsuko Tanji; Masahito Kawazu; Toyoyuki Hanazawa; Yosuke Togashi
Source: check_circle
Crossref

Supplementary Tables from High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects

2023-07-05 | Preprint
DOI: 10.1158/2326-6066.23627516.v1
Contributors: Katsushige Kawase; Shusuke Kawashima; Joji Nagasaki; Takashi Inozume; Etsuko Tanji; Masahito Kawazu; Toyoyuki Hanazawa; Yosuke Togashi
Source: check_circle
Crossref

Supplementary Tables from High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects

2023-07-05 | Preprint
DOI: 10.1158/2326-6066.23627516
Contributors: Katsushige Kawase; Shusuke Kawashima; Joji Nagasaki; Takashi Inozume; Etsuko Tanji; Masahito Kawazu; Toyoyuki Hanazawa; Yosuke Togashi
Source: check_circle
Crossref

Data from High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects

2023-04-16 | Preprint
DOI: 10.1158/2326-6066.c.6601461.v1
Contributors: Katsushige Kawase; Shusuke Kawashima; Joji Nagasaki; Takashi Inozume; Etsuko Tanji; Masahito Kawazu; Toyoyuki Hanazawa; Yosuke Togashi
Source: check_circle
Crossref

Supplementary Figures from High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects

2023-04-16 | Preprint
DOI: 10.1158/2326-6066.22640286
Contributors: Katsushige Kawase; Shusuke Kawashima; Joji Nagasaki; Takashi Inozume; Etsuko Tanji; Masahito Kawazu; Toyoyuki Hanazawa; Yosuke Togashi
Source: check_circle
Crossref

Supplementary Figures from High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects

2023-04-16 | Preprint
DOI: 10.1158/2326-6066.22640286.v1
Contributors: Katsushige Kawase; Shusuke Kawashima; Joji Nagasaki; Takashi Inozume; Etsuko Tanji; Masahito Kawazu; Toyoyuki Hanazawa; Yosuke Togashi
Source: check_circle
Crossref

Supplementary Tables from High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects

2023-04-16 | Preprint
DOI: 10.1158/2326-6066.22640283.v1
Contributors: Katsushige Kawase; Shusuke Kawashima; Joji Nagasaki; Takashi Inozume; Etsuko Tanji; Masahito Kawazu; Toyoyuki Hanazawa; Yosuke Togashi
Source: check_circle
Crossref

Supplementary Tables from High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects

2023-04-16 | Preprint
DOI: 10.1158/2326-6066.22640283
Contributors: Katsushige Kawase; Shusuke Kawashima; Joji Nagasaki; Takashi Inozume; Etsuko Tanji; Masahito Kawazu; Toyoyuki Hanazawa; Yosuke Togashi
Source: check_circle
Crossref

PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes.

Cell reports
2022-02-01 | Journal article
DOI: 10.1016/j.celrep.2022.110331
PMID: 35108529
Contributors: Katsushige Kawase
Source: Self-asserted source
Katsushige Kawase

Transcript-targeted analysis reveals isoform alterations and double-hop fusions in breast cancer

Communications Biology
2021-11-22 | Journal article
DOI: 10.1038/s42003-021-02833-4
Contributors: Shinichi Namba; Toshihide Ueno; Shinya Kojima; Kenya Kobayashi; Katsushige Kawase; Yosuke Tanaka; Satoshi Inoue; Fumishi Kishigami; Shusuke Kawashima; Noriko Maeda et al.
Source: check_circle
Crossref
How many people are using ORCID?